GEMA-Na：解决 MELD-肌酐难题的关键一步

IF 26.8 1区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY

Journal of Hepatology Pub Date : 2024-11-15 DOI:10.1016/j.jhep.2024.11.016

Avik Majumdar, Manuel Luis Rodríguez-Perálvarez, Emmanuel Tsochatzis

{"title":"GEMA-Na：解决 MELD-肌酐难题的关键一步","authors":"Avik Majumdar, Manuel Luis Rodríguez-Perálvarez, Emmanuel Tsochatzis","doi":"10.1016/j.jhep.2024.11.016","DOIUrl":null,"url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Authors Contributions</h2>AM drafted the letter. All authors (AM, MRP and ET) contributed equally to the study concept, reviewed and approved the final version of letter.</section></section><section><section><h2>Financial Support</h2>NilGEMA-Na: a crucial step in solving to the MELD-Creatinine dilemmaWe read with great interest the study by Dr Rosenstengle and colleagues examining MELD subtypes and the effect on intention-to-treat survival using the Scientific Registry of Transplant Recipients<sup>1</sup>. In their comprehensive analysis, the authors clearly demonstrate that the creatinine subtype of MELD (MELD-Cr) conferred inferior survival at one-year compared to bilirubin or INR subtypes. Furthermore, females had poorer survival</section></section><section><section><h2>Declaration of Competing Interest</h2>No relevant conflicts of interest</section></section>","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":"78 1","pages":""},"PeriodicalIF":26.8000,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"GEMA-Na: a crucial step in solving the MELD-Creatinine dilemma\",\"authors\":\"Avik Majumdar, Manuel Luis Rodríguez-Perálvarez, Emmanuel Tsochatzis\",\"doi\":\"10.1016/j.jhep.2024.11.016\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<h2>Section snippets</h2><section><section><h2>Authors Contributions</h2>AM drafted the letter. All authors (AM, MRP and ET) contributed equally to the study concept, reviewed and approved the final version of letter.</section></section><section><section><h2>Financial Support</h2>NilGEMA-Na: a crucial step in solving to the MELD-Creatinine dilemmaWe read with great interest the study by Dr Rosenstengle and colleagues examining MELD subtypes and the effect on intention-to-treat survival using the Scientific Registry of Transplant Recipients<sup>1</sup>. In their comprehensive analysis, the authors clearly demonstrate that the creatinine subtype of MELD (MELD-Cr) conferred inferior survival at one-year compared to bilirubin or INR subtypes. Furthermore, females had poorer survival</section></section><section><section><h2>Declaration of Competing Interest</h2>No relevant conflicts of interest</section></section>\",\"PeriodicalId\":15888,\"journal\":{\"name\":\"Journal of Hepatology\",\"volume\":\"78 1\",\"pages\":\"\"},\"PeriodicalIF\":26.8000,\"publicationDate\":\"2024-11-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Hepatology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jhep.2024.11.016\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jhep.2024.11.016","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

章节片段作者贡献AM起草了这封信。所有作者（AM、MRP 和 ET）对研究概念的贡献相同，并审阅和批准了信件的最终版本。财务支持NilGEMA-Na：解决 MELD-肌酐困境的关键一步我们饶有兴趣地阅读了 Rosenstengle 博士及其同事利用移植受者科学登记处（Scientific Registry of Transplant Recipients）对 MELD 亚型及其对意向治疗生存率的影响进行的研究1。在他们的综合分析中，作者清楚地表明，与胆红素或 INR 亚型相比，MELD 的肌酐亚型（MELD-Cr）会降低一年的生存率。此外，女性的生存率较低。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

GEMA-Na: a crucial step in solving the MELD-Creatinine dilemma

Section snippets

Authors Contributions

AM drafted the letter. All authors (AM, MRP and ET) contributed equally to the study concept, reviewed and approved the final version of letter.

Financial Support

NilGEMA-Na: a crucial step in solving to the MELD-Creatinine dilemmaWe read with great interest the study by Dr Rosenstengle and colleagues examining MELD subtypes and the effect on intention-to-treat survival using the Scientific Registry of Transplant Recipients¹. In their comprehensive analysis, the authors clearly demonstrate that the creatinine subtype of MELD (MELD-Cr) conferred inferior survival at one-year compared to bilirubin or INR subtypes. Furthermore, females had poorer survival

Declaration of Competing Interest

No relevant conflicts of interest

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of Hepatology 医学-胃肠肝病学

CiteScore

46.10

自引率

4.30%

发文量

2325

审稿时长

30 days

期刊介绍： The Journal of Hepatology is the official publication of the European Association for the Study of the Liver (EASL). It is dedicated to presenting clinical and basic research in the field of hepatology through original papers, reviews, case reports, and letters to the Editor. The Journal is published in English and may consider supplements that pass an editorial review.